The A, B, BI, and Cs of clostridium difficile

Clinical Infectious Diseases

Volumn 49, Issue 8, 2009, Pages 1148-1152

  Dubberke, Erik R ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN;

BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; CELL HETEROGENEITY; CLOSTRIDIUM DIFFICILE; DISEASE TRANSMISSION; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; ISOLATION PROCEDURE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR EPIDEMIOLOGY; NONHUMAN; NOTE; NURSE; PRIORITY JOURNAL; RESTRICTION MAPPING; RISK ASSESSMENT; VANCOMYCIN RESISTANT ENTEROCOCCUS;

BACTERIAL TYPING TECHNIQUES; CLOSTRIDIUM DIFFICILE; CROSS INFECTION; ENTEROCOLITIS, PSEUDOMEMBRANOUS; EPIDEMIOLOGY, MOLECULAR; GENOTYPE; HUMANS; INCIDENCE; INFECTION CONTROL;

EID: 70349895527     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/605639     Document Type: Note

References (42)

1. Belmares J, Johnson S, Parada JP, et al. Molecular epidemiology of Clostridium difficile over the course of 10 years in a tertiary care hospital. Clin Infect Dis 2009;49:1141-1147 (in this issue).
2. Brazier JS, Raybould R, Patel B, et al. Distribution and antimicrobial susceptibility patterns of Clostridium difficile PCR ribotypes in English hospitals, 2007-2008. Euro Surveill 2008; 13:19000.
3. Kuijper EJ, Barbut F, Brazier JS, et al. Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. Euro Surveill 2008; 13:18942.
4. Terhes G, Brazier JS, Urban E, Soki J, Nagy E. Distribution of Clostridium difficile PCR ribotypes in regions of Hungary. J Med Microbiol 2006; 55:279-282
5. Samore MH, Bettin KM, DeGirolami PC, Clabots CR, Gerding DN, Karchmer AW. Wide diversity of Clostridium difficile types at a tertiary referral hospital. J Infect Dis 1994; 170: 615-621
6. Sawabe E, Kato H, Osawa K, et al. Molecular analysis of Clostridium difficile at a university teaching hospital in Japan: a shift in the predominant type over a five-year period. Eur J Clin Microbiol Infect Dis 2007;26:695-703.
7. Spigaglia P, Cardines R, Rossi S, Menozzi MG, Mastrantonio P. Molecular typing and longterm comparison of Clostridium difficile strains by pulsed-field gel electrophoresis and PCR-ribotyping. J Med Microbiol 2001;50:407-414
8. MacCannell DR, Louie TJ, Gregson DB, et al. Molecular analysis of Clostridium difficile PCR ribotype 027 isolates from eastern and western Canada. J Clin Microbiol 2006;44:2147-2152
9. Gerding DN, Olson MM, Johnson S, Peterson LR, Lee JT Jr. Clostridium difficile diarrhea and colonization after treatment with abdominal infection regimens containing clindamycin or metronidazole. Am J Surg 1990;159:212-217
10. Clabots CR, Peterson LR, Gerding DN. Characterization of a nosocomial Clostridium difficile outbreak by using plasmid profile typing and clindamycin susceptibility testing. J Infect Dis 1988; 158:731-736
11. Gerding DN, Olson MM, Peterson LR, et al. Clostridium difficile-associated diarrhea and colitis in adults: a prospective case-controlled epidemiologic study. Arch Intern Med 1986; 146:95-100.
12. Olson MM, Shanholtzer CJ, Lee JT Jr, Gerding DN. Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982-1991. Infect Control Hosp Epidemiol 1994;15:371-381
13. Johnson S, Gerding DN, Olson MM, et al. Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission. Am J Med 1990;88:137-140
14. Johnson S, Clabots CR, Linn FV, Olson MM, Peterson LR, Gerding DN. Nosocomial Clostridium difficile colonisation and disease. Lancet 1990;336:97-100.
15. Clabots CR, Johnson S, Olson MM, Peterson LR, Gerding DN. Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. J Infect Dis 1992; 166:561-567
16. Miller LG, Perdreau-Remington F, Bayer AS, et al. Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin- susceptible S. aureus infection: a prospective investigation. Clin Infect Dis 2007;44:471-482
17. Edgeworth JD, Yadegarfar G, Pathak S, et al. An outbreak in an intensive care unit of a strain of methicillin-resistant Staphylococcus aureus sequence type 239 associated with an increased rate of vascular access device-related bacteremia. Clin Infect Dis 2007;44:493-501.
18. Fridkin SK, Yokoe DS, Whitney CG, Onderdonk A, Hooper DC. Epidemiology of a dominant clonal strain of vancomycin-reistant Enterococcus faecium at separate hospitals in Boston, Massachusetts. J Clin Microbiol 1998; 36:965-970
19. Dubberke ER, Gerding DN, Classen D, et al. Strategies to prevent Clostridium difficile infections in acute care hospitals. Infect Control Hosp Epidemiol 2008; 29(Suppl 1):S81-92.
20. Fowler S, Webber A, Cooper BS, et al. Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficileinfection: a controlled interrupted time series. J Antimicrob Chemother 2007;59:990-995
21. Johnson S, Samore MH, Farrow KA, et al. Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals. N Engl J Med 1999; 341: 1645-1651
22. Valiquette L, Cossette B, Garant MP, Diab H, Pepin J. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium diffiale-assocvxted disease caused by the hypervirulent NAP1/027 strain. Clin Infect Dis 2007;45(Suppl 2): S112-21.
23. McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989; 320:204-210
24. Samore MH, Venkataraman L, DeGirolami PC, Arbeit RD, Karchmer AW. Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. Am J Med 1996; 100:32-40.
25. Peterson LR, Manson RU, Paule SM, et al. Detection of toxigenic Clostridium difficile in stool samples by real-time polymerase chain reaction for the diagnosis of C. difficile-associated diarrhea. Clin Infect Dis 2007; 45: 1152-1160
26. Akerlund T, Svenungsson B, Lagergren A, Burman LG. Correlation of disease severity with fecal toxin levels in patients with Clostridium difficile-associated diarrhea and distribution of PCR ribotypes and toxin yields in vitro of corresponding isolates. J Clin Microbiol 2006;44:353-358
27. Dubberke ER, Butler AM, Reske KA, et al. Attributable outcomes of endemic Clostridium difficile-associated disease in nonsurgical patients. Emerg Infect Dis 2008;14:1031-1038
28. Belmares J, Gerding DN, Parada JP, Miskevics S, Weaver F, Johnson S. Outcome of metronidazole therapy for Clostridium difficile disease and correlation with a scoring system. J Infect 2007;55:495-501.
29. Fernandez A, Anand G, Friedenberg F. Factors associated with failure of metronidazole in Clostridium difficile-associated disease. J Clin Gastroenterol 2004;38:414-418
30. Lagrotteria D, Holmes S, Smieja M, Smaill F, Lee C. Prospective, randomized inpatient study of oral metronidazole versus oral metronidazole and rifampin for treatment of primary episode of Clostridium difficile-associated diarrhea. Clin Infect Dis 2006; 43:547-552
31. Musher DM, Aslam S, Logan N, et al. Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Clin Infect Dis 2005;40:1586-1590
32. Pepin J, Valiquette L, Gagnon S, Routhier S, Brazeau I. Outcomes of Clostridium difficile associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027. Am J Gastroenterol 2007; 102: 2781-2788
33. Scheinfeld N, Biggers K. Tolevamer, an orally administered, toxin-binding polymer for Clostridium difficile-associated diarrhea. Curr Opin Investig Drugs 2008;9:913-924
34. Hu MY, Maroo S, Kyne L, et al. A prospective study of risk factors and historical trends in metronidazole failure for Clostridium difficile infection. Clin Gastroenterol Hepatol 2008; 6: 1354-1360
35. Dubberke ER, Butler AM, Reske KA, et al. Trends in community onset Clostridium difficile-associated disease in a hospital setting [abstract 827]. In: Program and abstracts of the 45th Annual Meeting of the Infectious Diseases Society of America (San Diego). Arlington, VA: Infectious Diseases Society of America, 2007.
36. McDonald LC, Coignard B, Dubberke E, Song X, Horan T, Kutty PK. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 2007; 28:140-145
37. Bakri MM, Brown DJ, Butcher JP, Sutherland AD. Clostridium difficile in ready-to-eat salads, Scodand. Emerg Infect Dis 2009; 15:817-818
38. Jhung MA, Thompson AD, Killgore GE, et al. Toxinotype V Clostridium difficile in humans and food animals. Emerg Infect Dis 2008; 14: 1039-1045
39. Songer JG, Trinh HT, Killgore GE, Thompson AD, McDonald LC, Limbago BM. Clostridium difficile in retail meat products, USA, 2007. Emerg Infect Dis 2009; 15:819-821
40. Stabler RA, Gerding DN, Songer JG, et al. Comparative phylogenomics of Clostridium difficile reveals clade specificity and microevolution of hypervirulent strains. J Bacteriol 2006; 188:7297-7305
41. US Department of Health and Human Services. HHS action plan to prevent healthcare-associated infections. Available at: http://www.hhs.gov/ophs/ initiativcs/hai/draft-hai-plan-01062009.pdf. Accessed 12 June 2009.
42. Janvilisri T, Scaria J, Thompson AD, et al. Microarray identification of Clostridium difficile core components and divergent regions associated with host origin. J Bacteriol 2009; 191: 3881-3891